Peter Verdult

Item: Peter Verdult
Rating: 0.42
Author: StockAnalysis.com

Stock Analyst at Citigroup

(0.42)

# 4,236

Out of 5,154 analysts

Total ratings

33.33%

Success rate

-15.21%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Peter Verdult

Stock	Action	Price Target	Current	Upside	Ratings	Updated
LLY Eli Lilly and Company	Maintains: Buy	$1,250 → $1,500	$990.33	+51.46%	4	Nov 12, 2025
EVO Evotec SE	Upgrades: Buy	n/a	$3.08	-	1	Jun 8, 2023
GLPG Galapagos NV	Upgrades: Buy	n/a	$32.92	-	1	Jan 27, 2022

Eli Lilly and Company

Nov 12, 2025

Maintains: Buy

Price Target: $1,250 → $1,500

Current: $990.33

Upside: +51.46%

Evotec SE

Jun 8, 2023

Upgrades: Buy

Price Target: n/a

Current: $3.08

Upside: -

Galapagos NV

Jan 27, 2022

Upgrades: Buy

Price Target: n/a

Current: $32.92

Upside: -